Dr Febrina Sandra
B. Pharm – Brawijaya University, Indonesia (2013)
M. Pharm (by research) – Korea University, South Korea (2014)
Ph.D Molecular Science – Macquarie University, Australia (2018)
Febrina Sandra (Sandra) joined the UNSW RNA Institute in 2021. She leads the production of RNA – lipid nanoparticles at the institute and also develops its quality control analysis. She is responsible for managing the projects, engaging clients and stakeholders, as well as providing training.
Sandra is a pharmacist by background, equipped with fundamental knowledge of pharmacology and pharmaceutical manufacturing/Good Manufacturing Practice. Through her research training at Korea University, she gained expertise in formulating nano-drug delivery systems for biomedical applications, and the skills to evaluate their pre-clinical safety and efficacy in cell and animal models. Her PhD training in bio-nanotechnology further expands her skill in molecular biology, particularly in downstream protein purification and analysis.
Sandra values an active lifestyle, on her day off you will find her on a badminton court or somewhere in the mountain, bushwalking.